Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cell Therapy Catapult & the UK Stem Cell Foundation Agree to Collaborate

Published: Wednesday, April 10, 2013
Last Updated: Wednesday, April 10, 2013
Bookmark and Share
Working together on next-generation medicines for patient benefit.

The Cell Therapy Catapult (CT Catapult), which is focused on the development of the UK cell therapy industry to increase the nation's health and wealth, and the UK Stem Cell Foundation, a charity focused on the advancement of stem cell treatments towards the clinic, are pleased to announce that they will be working together to progress promising stem cell-based therapies in the UK. The two organisations, which have entered into a memorandum of understanding to cover their co-operation, are both focused on translational activities, moving potential therapeutic approaches on from early-stage research to the later stages of development.

The CT Catapult and the charity aim to build a pipeline of projects that meet their criteria for support and funding on the route to commercialisation. Since 2005 the UKSCF has supported projects in a range of indications from spinal cord repair, ophthalmic, liver and cardiac disease, and tendon repair. Building on the UK's early stage research base, the CT Catapult is working on building a similarly broad pipeline. The two organisations will meet regularly to discuss projects and potential support packages, including other partners, contributing to the growth of the UK's emerging cell therapy industry.

Keith Thompson, CEO of the Cell Therapy Catapult, said, 'With the philanthropic sector an increasingly important source of life sciences research funding globally, we are very pleased to be working with the UK Stem Cell Foundation on the development of much needed therapies. The charity is a major UK funder in this area, and exemplifies the kind of high quality organisation the Cell Therapy Catapult expects to collaborate with as it works to build a thriving UK cell therapy industry.'

UKSCF’s CEO Lil Shortland said, 'It is clear that some of the projects we support fit within the remit of the Catapult and would benefit from the specialist support that it can provide. It is vital that there is a joined up approach between public, private and third sector organisations supporting the development of regenerative medicine products in the UK. Each sector has a role to play in realising the potential of stem cells to deliver not just health benefits but economic benefits for the UK and beyond.'


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!